Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Estradot 100 estradiol 100 microgram transdermal drug delivery system 8 pack
Section 19A approved medicine
(Approval lapsed) Estradot 100 estradiol 100 microgram transdermal drug delivery system 8 pack
Section 19A approval holder
Novartis Pharmaceuticals Australia Pty Ltd ABN 18 004 244 160
Phone
1800 671 203
Approved until
Status
Expired
Medicines in short supply/unavailable
ESTRADOT 100 estradiol 100 microgram transdermal drug delivery system sachet - ARTG 97566
Indication(s)
Short term oestrogen replacement therapy for the treatment of the symptoms of natural or surgically induced menopause. In women with an intact uterus, oestrogens should always be supplemented by administration of a progestogen.